B. Seddon et D. Mason, Deaggregated homologous immunoglobulin-peptide conjugates induce peptide-specific T cell nonresponsiveness in vivo, EUR J IMMUN, 28(12), 1998, pp. 4313-4324
Previous studies have proven the efficacy of intravenous injection of deagg
regated protein as a means of inducing tolerance. In the present study, the
immunodominant peptide 70-86 of myelin basic protein (MBP) was covalently
linked to either mouse Ig or Lewis rat IgG. Lewis rats immunized with MBP i
n complete Freund's adjuvant were completely protected from development of
experimental allergic encephalomyelitis (EAE) by their injection with as li
ttle as 40 mu g of peptide conjugate on days 0 and 10 after immunization. P
eptide-specific proliferative and cytokine responses by T cells from treate
d rats in vitro were severely depressed compared with controls, while respo
nses to whole MBP were unaffected. Significantly, injections of 100 mu g of
peptide conjugate on days 0 and 4 after adoptive transfer of peptide-speci
fic T lines protected rats from passive EAE while a single injection of 100
mu g of conjugate at the onset of active EAE prevented any further disease
progression. Both results suggest that primed effector cells as well as na
ive T cells are prone to tolerance induction by this means. The ability to
intervene in ongoing immune responses with such specificity may be useful t
herapeutically in control of autoimmunity or allergic responses to environm
ental antigens.